STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with STAAR Management at the upcoming Stephens Annual Investment Conference, which will be held in Nashville, TN.
Event: Stephens Annual Investment Conference (NASH2024)
Management Attendee: Patrick F. Williams, Chief Financial Officer
Date: Wednesday, November 20, 2024
Time: 11:00 a.m. ET / 8:00 a.m. PT
Location: Live Webcast
The live webcast link includes an option to pre-register. An online replay of the webcast will also be available on STAAR’s investor website at https://investors.staar.com/.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL,” which includes the EVO ICL™ product line. More than 3,000,000 ICLs have been sold to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: EVOICL.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241113681040/en/
Contacts
Investors & Media
Brian Moore
Vice President, Investor Relations and Corporate Development
(626) 303-7902, Ext. 3023
bmoore@staar.com
Connie Johnson
Director, Investor Relations and HPMS
(626) 303-7902, Ext. 2207
cjohnson@staar.com
